MME Gene (Membrane Metalloendopeptidase)
CD10, Neprilysin, Neutral Endopeptidase
Gene Information Card
| Symbol | MME |
|---|---|
| Full Name | Membrane Metalloendopeptidase |
| Gene Type | Protein coding |
| Chromosomal Location | 3q25.2 |
| NCBI Gene ID | 4311 ncbi.nlm.nih.gov/gene/4311 |
| Ensembl ID | ENSG00000196549 |
| UniProt ID | P08473 |
| OMIM ID | 120520 |
| HGNC ID | 7154 |
| Aliases | CD10, CALLA, NEP, SFE, gp100 |
Description
The MME gene encodes a type II transmembrane zinc-dependent metalloprotease known as neprilysin (CD10). It cleaves various bioactive peptides, including enkephalins, substance P, endothelin, and amyloid beta peptide. Neprilysin is expressed on the surface of many cell types and plays a critical role in peptide hormone regulation, pain modulation, and blood pressure control. It is also a well-known marker for acute lymphoblastic leukemia (CALLA antigen).
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Alzheimer disease | Neprilysin degrades amyloid beta peptide; reduced activity leads to amyloid plaque accumulation | PMID: 15339662 |
| Acute lymphoblastic leukemia | CD10 (CALLA) is a diagnostic marker; MME expression is characteristic of precursor B-cell ALL | PMID: 2687500 |
| Hereditary sensory neuropathy type IE | Missense mutations in MME cause loss of neprilysin activity, leading to neurodegeneration | PMID: 26991897 |
| Essential hypertension | Neprilysin degrades vasoactive peptides; MME polymorphisms associated with blood pressure regulation | PMID: 10471492 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Kidney | 68.5 | High |
| Small intestine | 42.3 | High |
| Lung | 28.1 | Medium |
| Brain | 15.2 | Medium |
| Liver | 2.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 45.0 | High expression |
| K-562 | 12.3 | Moderate expression |
| HeLa | 3.5 | Low expression |
| SH-SY5Y | 8.9 | Moderate expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1118C>T (p.Thr373Ile) | Missense | Rare | Loss of catalytic activity; associated with hereditary sensory neuropathy |
| c.1579G>A (p.Val527Met) | Missense | Rare | Reduced neprilysin activity; linked to Alzheimer risk |
| c.2041C>T (p.Arg681*), | Nonsense | Very rare | Truncated protein; loss of function |
Mutation functional classification
Loss of Function (LOF)
Missense and nonsense mutations that reduce or abolish neprilysin enzymatic activity, leading to impaired peptide degradation.
Gain of Function (GOF)
Not reported for MME.
Dominant Negative (DN)
Not reported for MME.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Amyloid beta metabolism (Reactome: R-HSA-977225)
• Peptide hormone metabolism (Reactome: R-HSA-422085)
• Endothelin degradation (Reactome: R-HSA-2022377)
Protein Summary
Neprilysin (CD10) is a 749-amino acid zinc metalloprotease anchored to the plasma membrane. It has a short N-terminal cytoplasmic domain, a transmembrane helix, and a large extracellular catalytic domain. The enzyme cleaves peptides at the amino side of hydrophobic residues, regulating signaling peptides such as enkephalins, substance P, bradykinin, and amyloid beta. It is a key drug target for heart failure (sacubitril) and is implicated in Alzheimer disease and cancer.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AMMECR1 Knockout HEK293 Cell Line | EDJ-KQ6187 | Human | 9949 | Details Get a Quote |
| AMMECR1L Knockout HEK293 Cell Line | EDJ-KQ9870 | Human | 83607 | Details Get a Quote |
| MMEL1 Knockout HEK293 Cell Line | EDJ-KQ10785 | Human | 79258 | Details Get a Quote |
| MME Knockout HEK293 Cell Line | EDJ-KQ17789 | Human | 4311 | Details Get a Quote |
| AMMECR1 Knockout A-549 Cell Line | EDJ-KQ31382 | Human | 9949 | Details Get a Quote |
| AMMECR1 Knockout HCT 116 Cell Line | EDJ-KQ31383 | Human | 9949 | Details Get a Quote |
| AMMECR1 Knockout HeLa Cell Line | EDJ-KQ31384 | Human | 9949 | Details Get a Quote |
| AMMECR1L Knockout A-549 Cell Line | EDJ-KQ36743 | Human | 83607 | Details Get a Quote |
| AMMECR1L Knockout HCT 116 Cell Line | EDJ-KQ36744 | Human | 83607 | Details Get a Quote |
| AMMECR1L Knockout HeLa Cell Line | EDJ-KQ36745 | Human | 83607 | Details Get a Quote |
| MMEL1 Knockout HCT 116 Cell Line | EDJ-KQ38416 | Human | 79258 | Details Get a Quote |
| MME Knockout HeLa Cell Line | EDJ-KQ53881 | Human | 4311 | Details Get a Quote |
| MMEL1 Knockout HeLa Cell Line | EDJ-KQ57157 | Human | 79258 | Details Get a Quote |
| MME Knockout A-549 Cell Line | EDJ-KQ62372 | Human | 4311 | Details Get a Quote |
| MMEL1 Knockout A-549 Cell Line | EDJ-KQ65671 | Human | 79258 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records